185 related articles for article (PubMed ID: 31582824)
1. Fully automated head-twitch detection system for the study of 5-HT
de la Fuente Revenga M; Shin JM; Vohra HZ; Hideshima KS; Schneck M; Poklis JL; González-Maeso J
Sci Rep; 2019 Oct; 9(1):14247. PubMed ID: 31582824
[TBL] [Abstract][Full Text] [Related]
2. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
[TBL] [Abstract][Full Text] [Related]
4. Behavioral arrest and a characteristic slow waveform are hallmark responses to selective 5-HT
Contreras A; Khumnark M; Hines RM; Hines DJ
Sci Rep; 2021 Jan; 11(1):1925. PubMed ID: 33479368
[TBL] [Abstract][Full Text] [Related]
5. Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HT
Gao H; Liu X; Xie L; Tan B; Su R
Neurochem Res; 2024 Mar; 49(3):636-648. PubMed ID: 37989895
[TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
7. Differences across sexes on head-twitch behavior and 5-HT
Jaster AM; Younkin J; Cuddy T; de la Fuente Revenga M; Poklis JL; Dozmorov MG; González-Maeso J
Neurosci Lett; 2022 Sep; 788():136836. PubMed ID: 35963476
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD
Neuropharmacology; 2020 May; 167():107933. PubMed ID: 31917152
[TBL] [Abstract][Full Text] [Related]
9. Effects of the 5-HT
Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
[TBL] [Abstract][Full Text] [Related]
10. The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in mice.
Malik M; Rangel-Barajas C; Mach RH; Luedtke RR
Pharmacol Biochem Behav; 2016 Sep; 148():136-44. PubMed ID: 27397487
[TBL] [Abstract][Full Text] [Related]
11. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.
Santini MA; Balu DT; Puhl MD; Hill-Smith TE; Berg AR; Lucki I; Mikkelsen JD; Coyle JT
Behav Brain Res; 2014 Feb; 259():242-6. PubMed ID: 24269270
[TBL] [Abstract][Full Text] [Related]
12. Automated Detection of Psychedelic-Induced Head-Twitch Response in Mice.
Jaster AM; González-Maeso J
Methods Mol Biol; 2023; 2687():65-76. PubMed ID: 37464163
[TBL] [Abstract][Full Text] [Related]
13. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.
Klein LM; Cozzi NV; Daley PF; Brandt SD; Halberstadt AL
Neuropharmacology; 2018 Nov; 142():231-239. PubMed ID: 29499272
[TBL] [Abstract][Full Text] [Related]
16. Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines.
Halberstadt AL; Luethi D; Hoener MC; Trachsel D; Brandt SD; Liechti ME
Psychopharmacology (Berl); 2023 Jan; 240(1):115-126. PubMed ID: 36477925
[TBL] [Abstract][Full Text] [Related]
17. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
18. Molecular and behavioral pharmacology of two novel orally-active 5HT2 modulators: potential utility as antipsychotic medications.
Morgan D; Kondabolu K; Kuipers A; Sakhuja R; Robertson KL; Rowland NE; Booth RG
Neuropharmacology; 2013 Sep; 72():274-81. PubMed ID: 23665356
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.
Halberstadt AL; Chatha M; Chapman SJ; Brandt SD
J Psychopharmacol; 2019 Mar; 33(3):406-414. PubMed ID: 30789291
[TBL] [Abstract][Full Text] [Related]
20. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.
Canal CE; Morgan D
Drug Test Anal; 2012; 4(7-8):556-76. PubMed ID: 22517680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
